Shanghai Fudan Forward S&T Co., Ltd (SHSE: 600624)
Health Care · Pharmaceuticals · CN
CN¥4.06
-1.46% today · -44.9% 1Y
Shanghai Fudan Forward S&T Co., Ltd (SHSE: 600624) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $410.29M and employs 1,355 people.
Over the last twelve months the share price has lost 44.9%, trading between 3.18 and 7.66.
Tweenvest scores Shanghai Fudan Forward S&T Co., Ltd across four factors: quality 49/100, value 45/100, growth 0/100. Its strongest factor is quality.
600624 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $410.29M
- Revenue (TTM)
- $91.10M
- P/E
- —
- EPS
- -0.29
- Dividend yield
- —
- Beta (5Y)
- 0.22
- 52-week high
- CN¥7.66
- 52-week low
- CN¥3.18
- Avg volume (3M)
- —
- Shares outstanding
- 679.35M
- Employees
- 1,355
- Next earnings
- —
About Shanghai Fudan Forward S&T Co., Ltd
Shanghai Fudan Forward S&T Co., Ltd maintains a diverse business portfolio encompassing software development, biopharmaceuticals, and property ventures. Its software division specializes in creating and exporting programs, notably to the Japanese market. Within its biopharmaceutical operations, the firm conducts comprehensive research, development, manufacturing, and distribution of a range of products, including chemical drugs, traditional Chinese medicines, freeze-dried powder injections, and various solid dosage forms. The company's real estate arm focuses on the conceptualization and establishment of high-tech industrial parks. Beyond these, the enterprise is involved in the design, production, and sale of uninterruptible power supplies (UPS) and VRLA batteries, and also serves as an official agent for an automotive audio brand. Complementing these activities, it provides investment and advisory services, alongside venture capital funding. Founded in 1984, Shanghai Fudan Forward S&T Co., Ltd is headquartered in Shanghai, China.
- ISIN
- CNE0000006S1
- Founded
- 1984
- Listed since
- Jan 5, 1993
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.